CStone Pharmaceuticals completes placing of new shares

CStone Pharmaceuticals announced the completion of its placing of new shares, effective April 10, 2025. The company successfully placed 80,000,000 shares via Morgan Stanley, the sole placing agent, coordinator, and bookrunner, at a price of HKD2.933 per share. This placement represents approximately 5.86% of the company's enlarged issued share capital. The investors are reportedly professional, institutional or other investors who are Independent Third Parties. CStone expects to receive net proceeds of approximately HKD232.29 million from the placing, after deducting commission and related expenses, and intends to use the funds as previously disclosed in its April 2 announcement. Post-placement, the Placees will hold 5.86% of shares and other shareholders will hold 94.14% of shares.